000 01356 a2200373 4500
005 20250510205543.0
264 0 _c19800124
008 198001s 0 0 eng d
022 _a0022-3573
024 7 _a10.1111/j.2042-7158.1979.tb13597.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVallee, E
245 0 0 _aAnti-inflammatory and platelet anti-aggregant activity of phospholipase-A2 inhibitors.
_h[electronic resource]
260 _bThe Journal of pharmacy and pharmacology
_cSep 1979
300 _a588-92 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnti-Inflammatory Agents
650 0 4 _aBlood Platelets
_xenzymology
650 0 4 _aCalcimycin
_xpharmacology
650 0 4 _aHumans
650 0 4 _aIn Vitro Techniques
650 0 4 _aPapaverine
_xpharmacology
650 0 4 _aPhospholipases
_xantagonists & inhibitors
650 0 4 _aPhospholipases A
_xantagonists & inhibitors
650 0 4 _aPhospholipases A2
650 0 4 _aPlatelet Aggregation
_xdrug effects
650 0 4 _aQuinacrine
_xpharmacology
650 0 4 _aViper Venoms
_xanalysis
700 1 _aGougat, J
700 1 _aNavarro, J
700 1 _aDelahayes, J F
773 0 _tThe Journal of pharmacy and pharmacology
_gvol. 31
_gno. 9
_gp. 588-92
856 4 0 _uhttps://doi.org/10.1111/j.2042-7158.1979.tb13597.x
_zAvailable from publisher's website
999 _c40007
_d40007